Hughes Financial Services’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-52
Closed -$752 1882
2026
Q1
$752 Sell
52
-31
-37% -$444 ﹤0.01% 837
2025
Q4
$1.18K Hold
83
﹤0.01% 684
2025
Q3
$747 Hold
83
﹤0.01% 798
2025
Q2
$575 Buy
+83
New +$536 ﹤0.01% 890

Other funds holding FOLD

Hughes Financial Services's FOLD Position: Q2 2026 in Review

Hughes Financial Services sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 52 shares — an estimated $752 sold.

Hughes Financial Services first reported a position in FOLD in Q2 2025 and held it in 4 quarters. The position peaked at $1.18K in Q4 2025. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

  • Hughes Financial Services reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Hughes Financial Services sold 52 Amicus Therapeutics shares in Q2 2026, an estimated $752.
  • Hughes Financial Services first reported a position in Amicus Therapeutics in Q2 2025 and held it in 4 quarters.
  • Hughes Financial Services's Amicus Therapeutics position peaked at $1.18K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.